VRON-0200 alone and in combination with investigational antivirals for participants with chronic hepatitis B virus infection receiving stable nucleos(t)ide therapy: a phase 1b, randomised, open-label, multicentre trial.

tobevibart (VIR-3434) - Vir Biotech

VRON-0200 - Virion Therap

elebsiran (VIR-2218) - Alnylam, Vir Biotech

http://www.ncbi.nlm.nih.gov/pubmed/42214405

Andrew Luber; Edward Gane; Grace Lai-Hung Wong; Marie Bonhomme; Paula MacDonald; Sue Currie; Tien Huey Lim

May 30, 2026